Ocular therapy using sirtuin-activating agents

Details Ocular therapy using sirtuin-activating agents Ocular therapy using sirtuin-activating agents

A - Human Necessities

61

K

A61K 9/16 (2006.01) A61P 27/02 (2006.01)

Patent

CA 2643903

Ophthalmically therapeutic compositions, such as polymeric drug delivery systems, include a therapeutic component that includes a sirtuin-activating agent, such as resveratrol, which, upon delivery to the posterior segment of a mammalian eye, treats ocular conditions. Methods of making and using the present compositions are also described.

L'invention concerne des compositions thérapeutiques ophtalmiques, telles que des systèmes de libération de médicaments polymères, contenant un composant thérapeutique qui contient un agent activateur de la sirtuine, tel que le resveratol, qui traite les affections oculaires par libération sur la partie postérieure de l'oeil d'un mammifère. L'invention concerne également des procédés de fabrication et des méthodes d'utilisation de ces compositions.

Affiliated with

Also associated with

Rating

Ocular therapy using sirtuin-activating agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ocular therapy using sirtuin-activating agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ocular therapy using sirtuin-activating agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1724057